A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection
about
The Role of the Immune Response in Chlamydia trachomatis Infection of the Male Genital Tract: A Double-Edged SwordCollateral Damage: Detrimental Effect of Antibiotics on the Development of Protective Immune MemoryA vaccine formulated with the major outer membrane protein can protect C3H/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challengeLPS-induced TNF-alpha factor (LITAF)-deficient mice express reduced LPS-induced cytokine: Evidence for LITAF-dependent LPS signaling pathwaysInduction of protective immunity against Chlamydia muridarum intravaginal infection with a chlamydial glycogen phosphorylaseChlamydia trachomatis Genital Infections.Antibodies from women urogenitally infected with C. trachomatis predominantly recognized the plasmid protein pgp3 in a conformation-dependent mannerImmunobiological outcomes of repeated chlamydial infection from two models of within-host population dynamics.Chlamydial protease-like activity factor--insights into immunity and vaccine developmentProtection against Chlamydia promoted by a subunit vaccine (CTH1) compared with a primary intranasal infection in a mouse genital challenge model.Considerations for the rational design of a Chlamydia vaccineA MyD88-dependent early IL-17 production protects mice against airway infection with the obligate intracellular pathogen Chlamydia muridarum.Increased immunoaccessibility of MOMP epitopes in a vaccine formulated with amphipols may account for the very robust protection elicited against a vaginal challenge with Chlamydia muridarum.Simultaneous Subcutaneous and Intranasal Administration of a CAF01-Adjuvanted Chlamydia Vaccine Elicits Elevated IgA and Protective Th1/Th17 Responses in the Genital Tract.Immunization of a wild koala population with a recombinant Chlamydia pecorum Major Outer Membrane Protein (MOMP) or Polymorphic Membrane Protein (PMP) based vaccine: New insights into immune response, protection and clearanceDivergent outcomes following transcytosis of IgG targeting intracellular and extracellular chlamydial antigensThe Role of Non-Cognate T Cell Stimulation during Intracellular Bacterial Infection.Whole genome identification of C. trachomatis immunodominant antigens after genital tract infections and effect of antibiotic treatment of pigtailed macaques.Poly(lactic acid)-poly(ethylene glycol) nanoparticles provide sustained delivery of a Chlamydia trachomatis recombinant MOMP peptide and potentiate systemic adaptive immune responses in mice.Complement factor C5 but not C3 contributes significantly to hydrosalpinx development in mice infected with Chlamydia muridarum.Evaluation of a multisubunit recombinant polymorphic membrane protein and major outer membrane protein T cell vaccine against Chlamydia muridarum genital infection in three strains of mice.Immunization with a combination of integral chlamydial antigens and a defined secreted protein induces robust immunity against genital chlamydial challenge.CD4+ T cells and antibody are required for optimal major outer membrane protein vaccine-induced immunity to Chlamydia muridarum genital infection.The immune response against Chlamydia suis genital tract infection partially protects against re-infection.Induction of protective immunity against Chlamydia muridarum intravaginal infection with the chlamydial immunodominant antigen macrophage infectivity potentiator.Chlamydia trachomatis polymorphic membrane protein D is a species-common pan-neutralizing antigenIntranasal vaccination with a defined attenuated Francisella novicida strain induces gamma interferon-dependent antibody-mediated protection against tularemia.A new role of the complement system: C3 provides protection in a mouse model of lung infection with intracellular Chlamydia psittaci.Induction of immune memory by a multisubunit chlamydial vaccineTrachoma: protective and pathogenic ocular immune responses to Chlamydia trachomatis.Development of a Chlamydia trachomatis T cell Vaccine.Perforin is detrimental to controlling [corrected] C. muridarum replication in vitro, but not in vivo.Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.Murine Chlamydia trachomatis genital infection is unaltered by depletion of CD4+ T cells and diminished adaptive immunity.Intranasal vaccination with Chlamydia pneumoniae induces cross-species immunity against genital Chlamydia muridarum challenge in mice.Evaluation of a broadly protective Chlamydia-cholera combination vaccine candidate.Oviduct infection and hydrosalpinx in DBA1/j mice is induced by intracervical but not intravaginal inoculation with Chlamydia muridarum.The hypothetical protein CT813 is localized in the Chlamydia trachomatis inclusion membrane and is immunogenic in women urogenitally infected with C. trachomatis.A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice.The duration of Chlamydia muridarum genital tract infection and associated chronic pathological changes are reduced in IL-17 knockout mice but protection is not increased further by immunization.
P2860
Q26851537-A88806F5-4130-450A-9E35-1EF77E11A416Q28066947-61C7066A-B181-439A-AD27-421C96F279A2Q28391567-30995DEC-71CE-4B9B-8A01-89622E0581A2Q28510808-204B0E6F-C7CB-46F9-A5B2-426922D71C9AQ28731379-FDBA737F-DB3E-4A91-806F-A4A4B2E9F969Q30235030-BAC8F96E-538C-49E4-9F7B-5BA1A614F87EQ33341501-387D23A6-704A-4DE9-8D7D-B2D31A736AA8Q33499684-8CDAB4B5-8BDC-4364-8130-B348E512EA39Q33584064-43C25486-C75F-4A56-9B2E-66B5F518CD8BQ33588632-0D944D5E-0CDE-402E-BF7C-C99DD5BA03F2Q33601324-3C467C51-63BC-49C6-A551-F46BC18C60D9Q33606828-B26C3004-1CA8-48EC-A9B2-1B7E55C236C7Q33648677-2CA39A68-4107-4EA5-8400-8197EA51508DQ33694896-1DDB4D99-C296-4641-B5A5-1634AF5776B3Q33757880-25B26339-AC05-4F37-84CC-62AA70C461E3Q33870404-2BE5EB9D-D34A-4AC7-B7DA-E36E8DC49267Q33872734-F169CF5F-0A34-4AAA-991E-394629703428Q33957971-289765A3-924E-4382-A6E7-50F787A9221CQ33993714-C4BF9288-EB7D-4427-BB4B-B62B23EF47B4Q34059023-611192D2-1D50-4D13-B8AC-677227845FCFQ34103785-5250F873-F303-482D-A3F8-BFAA5AAC1851Q34119450-D826C16E-D71A-45DB-A37F-5A8EEBF4EB69Q34177368-9E983F16-AE55-40A6-A4B8-B20400ECD25DQ34274531-591BE485-901E-4ACA-8C56-5399154AD4DEQ34445366-3B46430E-6D37-46DE-A0F2-4B68A6B7FCF1Q34478609-E35630D5-EF33-451C-BAE9-F2D3FE3E7C5BQ34492667-FDC79749-F0DB-4E08-B2F3-3E2DA5205863Q34494082-FD31FB1D-843C-4883-958A-2657B33F7332Q34546923-12D77044-7102-4C82-BF5B-27FA1FB5FDB9Q34607259-217DCD31-A9DB-4BA6-92BE-8AACDDFDE0F8Q34663987-3CB2475C-A4BC-4149-8E6E-107AF0A17A20Q34730267-C9E7EC24-5DCC-4F1D-A758-F90BB61BD1AFQ34739969-CB276EAB-14FA-408C-B596-39776FAC8731Q34743290-E286CD5E-B1B2-403E-B28D-95D11FE30B4BQ34760989-0CA45603-6498-45A1-9E0F-63E42569C319Q34883543-93C146F1-863E-4EE5-8499-CCADD888824BQ34937975-6E0BE5EF-82C2-46C4-894E-EA5B18D8D4EDQ34975886-A4C559AF-7976-41AE-B9FA-2484D3D813AEQ34980175-64FA0B5B-120A-409F-9243-55FD01DDF136Q35000987-556CF7D6-192E-45D7-9A9C-AF9DBF82D139
P2860
A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
A predominant role for antibod ...... dial genital tract reinfection
@ast
A predominant role for antibod ...... dial genital tract reinfection
@en
type
label
A predominant role for antibod ...... dial genital tract reinfection
@ast
A predominant role for antibod ...... dial genital tract reinfection
@en
prefLabel
A predominant role for antibod ...... dial genital tract reinfection
@ast
A predominant role for antibod ...... dial genital tract reinfection
@en
P2860
P1476
A predominant role for antibod ...... dial genital tract reinfection
@en
P2093
Richard P Morrison
Sandra G Morrison
P2860
P304
P356
10.4049/JIMMUNOL.175.11.7536
P407
P577
2005-12-01T00:00:00Z